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SUMMARY
NuMA is a 236 kDa nuclear protein that is required for the
organization of the mitotic spindle. To determine how
NuMA redistributes in the cell during mitosis, we have
examined the behavior of NuMA in a mammalian mitotic
extract under conditions conducive to the reassembly of
interphase nuclei. NuMA is a soluble protein in mitotic
extracts prepared from synchronized cultured cells, but
forms insoluble structures when the extract becomes nonmitotic (as judged by the inactivation of cdc2/cyclin B
kinase and the disappearance of mpm-2-reactive antigens).
These NuMA-containing structures are irregularly shaped
particles of 1-2 µm in diameter and their assembly is
specific because other nuclear components such as the
lamins remain soluble in the extract under these conditions.
NuMA is dephosphorylated during this assembly process,

INTRODUCTION
Nuclei of vertebrate cells undergo profound physical
rearrangements during mitosis. These physical changes are
necessary for the efficient segregation of the chromosomes and
include the dissolution of the nuclear lamina, condensation of
the chromatin into chromosomes, and vesicularization of the
nuclear envelope (Newport and Forbes, 1987; Gerace and
Burke, 1988). Each of these structural changes is completely
reversible such that two daughter cell nuclei are assembled
during telophase from preexisting subunits that were generated
from the disassembly of the nucleus in prophase of the previous
mitosis. Thus, the subunits generated from the disassembly of
the nucleus at the onset of mitosis must be partitioned equally
into each daughter cell to ensure efficient assembly of the
daughter cell nuclei (Laskey and Leno, 1990; Fisher, 1987;
Marshall and Wilson, 1997; Wiese and Wilson, 1993). To date,
there have been three pathways described for the segregation
of nuclear components into the daughter cells. Nuclear components may either associate with the condensed chromosomes, undergo random diffusion, or associate with the mitotic
spindle, and examples of nuclear proteins that segregate during
mitosis using each of these mechanisms are topoisomerase II
(Gasser et al., 1986; Earnshaw and Heck, 1985), the nuclear
lamins (McKeon, 1991; Nigg, 1992; Gerace and Blobel, 1980),
and NuMA (nuclear-mitotic apparatus protein; Lydersen and

and the assembly of these NuMA-containing structures is
catalyzed by protein dephosphorylation because protein
kinase inhibitors enhance their formation and protein
phosphatase inhibitors block their formation. Finally,
immunodepletion demonstrates that NuMA is an essential
structural component of these insoluble particles, and
electron microscopy shows that the particles are composed
of a complex interconnected network of foci. These results
demonstrate that phosphorylation regulates the solubility
of NuMA in a mammalian mitotic extract, and the spontaneous assembly of NuMA into extensive structures upon
dephosphorylation supports the conclusion that NuMA
serves a structural function.
Key words: NuMA, Nucleus, Mitosis, Nuclear Matrix

Pettijohn, 1980; reviewed by Compton and Cleveland, 1994;
Cleveland, 1995), respectively.
NuMA is a 236 kDa protein that is required for the organization of microtubule minus ends at the mitotic spindle pole
(Gaglio et al., 1995, 1996; Merdes et al., 1996; Yang and
Snyder, 1992; Kallajoki et al., 1991). During interphase in both
dividing and non-dividing cells, however, NuMA is localized
uniformly throughout the interior of the nucleus as an insoluble
component of the nuclear matrix (Price and Pettijohn, 1986;
Compton et al., 1991, 1992; Kallajoki et al., 1991, 1992;
Tousson et al., 1991; Yang et al., 1992; Maekawa et al.,
1991; Tang et al., 1993; Zeng et al., 1994). Thus, there has been
speculation that NuMA may be a structural component of the
nuclear matrix. Experimental support for this proposal comes
from the localization of NuMA to a subset of the core filaments
of the nuclear matrix (Zeng et al., 1994), the perturbation of
nuclear assembly following mitosis upon disruption of NuMA
(Compton and Cleveland, 1993; Kallajoki et al., 1993), the
finding that NuMA is capable of assembling into extensive filamentous structures (Saredi et al., 1996), and the fact that
NuMA has an extensive α-helical coiled-coil structure
(Compton et al., 1992; Yang et al., 1992; Maekawa and
Kuriyama, 1993; Tang et al., 1993; Harborth et al., 1995).
Unfortunately, in the absence of any defined assay for specific
nuclear functions, no role for the NuMA protein in the nucleus
has been identified.
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In addition to characterizing the specific function of the
NuMA protein on the mitotic spindle and the proposed
function inside the nucleus, there has been significant effort
aimed at understanding how the dramatic mitotic redistribution
of the NuMA protein is regulated. Phosphorylation is likely to
regulate NuMA’s function and/or distribution during mitosis
and NuMA has been shown to be a phosphoprotein whose
phosphorylation peaks during mitosis (Price and Pettijohn,
1986; Compton and Luo, 1995; Hsu and Yeh, 1996; Sparks et
al., 1995). However, aside from a single report indicating that
p34cdc2/cyclin B phosphorylation may be necessary for the
accurate localization of NuMA during mitosis (Compton and
Luo, 1995), all of the data regarding the regulation of NuMA
during mitosis by phosphorylation are correlative in nature.
Thus, the functional consequences of the phosphorylation of
NuMA have not been thoroughly characterized.
In this article we use a cell free system derived from synchronized HeLa cells to examine the behavior of the NuMA
protein under conditions that are conducive to nuclear
assembly. The results presented here show that as an extract
prepared from synchronized HeLa cells becomes non-mitotic,
NuMA spontaneously assembles into large insoluble particles.
These particles form through a specific assembly process that
is strictly regulated by phosphorylation. Electron microscopy
demonstrates that these insoluble, NuMA-containing particles
are composed of an interconnected network of foci that
resemble the structures formed by NuMA when it is expressed
in the cell cytoplasm (Saredi et al., 1996), and immunodepletion demonstrates that NuMA is essential for their
formation. These results demonstrate that NuMA’s solubility
in a mitotic extract is controlled by protein phosphorylation
and supports the conclusion that NuMA is performing a structural function in the cell.

MATERIALS AND METHODS
Cell culture
The human HeLa cell line was maintained in DME containing 10%
FCS, 2 mM glutamine, 100 i.u./ml penicillin, and 0.1 µg/ml streptomycin. Cells were grown at 37°C in a humidified incubator with a 5%
CO2 atmosphere.
Preparation of mitotic extracts
HeLa cells were synchronized in the cell cycle by double block with
2 mM thymidine. After a release from thymidine block, the cells were
allowed to grow for 6 hours, and then nocodazole was added to a final
concentration of 40 ng/ml. The mitotic cells that accumulated during
the next 5 hours were collected by mitotic shake off. We typically
obtained between 107 to 108 cells from five T-150 cm2 tissue culture
flasks. The cells were collected by centrifugation at 1,500 rpm and
washed at 4°C twice with KPM(−) buffer (50 mM KCl, 50 mM Pipes,
pH 7.0, 10 mM EGTA, 2 mM MgCl2) and once with KPM(+) buffer
(50 mM KCl, 50 mM Pipes, pH 7.0, 10 mM EGTA, 2 mM MgCl2, 1
mM DTT) as described by Suprynowicz and Gerace (1986). Cells
were then Dounce homogenized at 4°C and at a concentration of
5×107 cells/ml in KPM(+) buffer containing 20 µg/ml cytochalasin B,
50 µg/ml phenylmethysulfonyl fluoride, and 5 µg/ml each of chemostatin, leupeptin, antipain and pepstatin. The crude cell extract was
then subjected to centrifugation at 100,000 g for 15 minutes at 4°C.
The supernatant was recovered, supplemented with 1 µg/ml nocodazole, and incubated with or without the addition of 3 mM ATP at
30°C for various times as indicated in the text. After incubation, a

sample of 5 µl was taken for immunofluorescence microscopy. The
remainder of the extract was subjected to sedimentation at 10,000 g
for 15 minutes at room temperature and separated into soluble and
insoluble fractions. Proteins from both the soluble and insoluble
fractions were solubilized by boiling for 6 minutes in SDS-PAGE
sample buffer.
For the depletion of NuMA, 100 µg of preimmune rabbit polyclonal
IgG or anti-NuMA rabbit polyclonal IgG were adsorbed onto 25 µl
of Protein A-conjugated agarose (Boehringer Mannheim, Indianapolis, IN) as described by Gaglio et al., 1995. The antibody-coupled
Protein A-agarose was washed three times in KPM(+) buffer, and
packed by centrifugation to remove the excess fluid. The agarose was
then resuspended with the mitotic extract and incubated for 35
minutes at 4°C. After this incubation the agarose was removed from
the extract by sedimentation at 15,000 g for 10 seconds. The process
was repeated twice to achieve a depletion efficiency of more than
95%.
NuMA was radiolabeled in the cell extract by supplementing the
extract with 60 µCi [γ-32P]ATP (160 µM final concentration ATP) and
preincubation at 30°C for 15 minutes. The ATP was removed by the
addition of 0.1 units of apyrase and the assembly of the NuMA-containing structures induced by incubation at 30°C for 120 minutes.
Following the assembly reaction, the soluble and insoluble fractions
were collected and the proteins solubilized by boiling for 5 minutes
in 2% SDS, 50 mM Tris-HCl, pH 6.8, 1 mM EDTA, 2 mM EGTA, 1
mM DTT, 10 mM sodium fluoride, and 10 mM sodium pyrophosphate. The excess SDS was scavenged by diluting the samples 8 fold
with 3.4% Triton X-100, 20 mM Tris-HCl, pH 7.4, 140 mM NaCl,
and 10 mM sodium pyrophosphate. NuMA was immunoprecipitated,
size fractionated on 5% SDS-PAGE, and processed for immunoblot
analysis as described below. An autoradiographic exposure was
obtained from the same immunoblot to determine phosphate incorporation into the NuMA protein as described by Compton and Luo
(1995).
Immunological techniques
Indirect immunofluorescence microscopy was performed essentially
as described by Compton et al. (1991). After incubation, 5 µl of the
extract was diluted into 20 µl of KPM(+) buffer, spotted onto a polyL-lysine coated glass coverslip and fixed by immersion in −20°C
methanol. Following fixation, primary antibodies were added to the
samples and incubated for 30 minutes at room temperature in a humidified chamber. Coverslips were washed in TBS (10 mM Tris-HCl, pH
7.5, 0.15 M NaCl) containing 1% bovine serum albumin and the
bound antibodies were detected with the appropriate Texas Red-conjugated secondary antibodies (Vector labs, Burlingame, CA). Coverslips were mounted in FITC-Guard (Testog, Chicago, IL) and
observed with a Nikon Optiphot microscope equipped for epifluorescence.
For western blots, proteins were separated by size by SDS-PAGE
and transferred to PVDF membrane (Millipore Corp., Bedford MA).
This membrane was blocked in TBS containing 5% nonfat milk for
30 minutes at room temperature, and the primary antibody incubated
for 4 hours at room temperature in TBS containing 1% nonfat milk.
Non-bound primary antibody was removed by washing three times for
3 minutes each in TBS and the bound antibody was detected using
horseradish peroxidase-conjugated Protein A or horseradish peroxidase-conjugated goat anti-mouse (Bio-Rad Co., Hercules, CA). Nonbound Protein A was removed by washing three times for 3 minutes
each in TBS and the bound Protein A was detected using enhanced
chemiluminescence (Amersham Corp., Arlington Heights, IL).
Electron microscopy
The extract was prepared, incubated and sedimented as described
under preparation of mitotic extracts, and the pellet was fixed with 2%
glutaraldehyde in 0.1 M Na-cacodylate buffer, pH 7.4, for 12 hours
at 4°C. Following fixation, the pellet was rinsed in 0.1 M Na-cacody-
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late buffer, post-fixed with 1% OsO4 in 0.1 M Na-cacodylate buffer
for 30 minutes at room temperature, and en-bloc stained in 2%
aqueous uranyl acetate. The sample was then dehydrated through a
graded series of ethanols and propylene oxide, and embedded in Epon
(LX112). Sections (60-70 nm) were prepared and stained with 2%
uranyl acetate in methanol for 20 minutes followed by 5 minutes in
Reynold’s lead citrate. Micrographs were taken at 80 or 100 kV on a
JEOL 100CX.
For the immunogold electron microscopy, the extract was prepared,
incubated and sedimented as described above, and the pellet was then
fixed in 1% glutaraldehyde in phosphate-buffered saline (PBS) for 30
minutes. All the following washes were performed for 15 minutes: the
pellet was washed twice with PBS and reduced by 3 washes with 0.5
mg/ml NaBH4. The pellet was further washed once with PBS and once
with PBS containing 1% bovine serum albumin (PBS + 1% BSA).
The anti-NuMA rabbit polyclonal IgG (Gaglio et al., 1995) was then
added at a concentration of 0.4 µg/ml in PBS + 1% BSA and incubated
for 12 hours. The sample was then washed three times with PBS +
1% BSA, and incubated for 75 minutes with a 1/50 dilution of goat
anti-rabbit conjugated with 5 nm gold particles (Nanoprobes Inc.,
Stony Brook, NY) in PBS + 1% BSA. The sample was then washed
once with PBS + 1% BSA, twice with PBS, and fixed with 2% glutaraldehyde in 0.1 M Na-cacodylate for 20 minutes. Following
fixation, the sample was rinsed twice in 0.1 M Na-cacodylate buffer,
post-fixed with 1% OsO4 in Na-cacodylate buffer for 30 minutes at
room temperature and embedded in Epon (LX112). Sections (60-70
nm) were prepared and stained with 2% aqueous uranyl acetate for 10
minutes. Micrographs were taken at 80 or 100 kV on a JEOL 100CX.
Histone H1 kinase assay
Histone H1 kinase activity was measured using 0.5 µl of the cell
extract in a reaction containing 0.2 mg/ml of histone H1, 20 mM TrisHCl, pH 7.2, 2 mM DTT, 1 mM EGTA, 10 µM ATP, and 2 µCi [γ32P]ATP. Reactions were incubated at 30°C for 15 minutes and
stopped by the addition of SDS-PAGE sample buffer. The histone was
separated from the nonincorporated nucleotide on a 12.5% SDSPAGE, the gel dried and exposed to X-ray film. Quantitation of the
histone H1 kinase activity was performed by densitometric scanning
of multiple different film exposures.

RESULTS
Solubility properties of NuMA in a mitotic extract
Burke and Gerace (1986) have shown that under dephosphorylating conditions chromosomes will serve as substrates
for the formation of structures resembling interphase nuclei
in mitotic extracts prepared from synchronized CHO cells.
Using synchronized HeLa cells, we have used a modification
of their protocol to examine the behavior of the human
NuMA protein under similar experimental conditions.
NuMA is a soluble component of crude extracts (100,000 g
supernatants) prepared from nocodazole-treated mitotic cells
(Fig. 1A, time 0′; Gaglio et al., 1995; Kempf et al., 1994;
Kallajoki et al., 1993; Maekawa et al., 1991). Upon incubation of this mitotic extract at 30°C, NuMA progressively
shifts from the soluble fraction to the 10,000 g insoluble
fraction. This dramatic change in the solubility of NuMA
under these conditions is dependent on incubation time, is
typically 50-60% efficient (ranging from 25% to 80%
depending on the extract), and maximizes after approximately 120 minutes of incubation (Fig. 1A, −ATP). In
addition, the conversion of NuMA from a soluble protein
into an insoluble protein is dependent on temperature and the
concentration of the mitotic extract because NuMA remains

Fig. 1. The solubility of NuMA in a mitotic extract. (A) A mitotic
extract was incubated at 30°C for the indicated times (minutes) either
with (+ATP) or without (−ATP) the addition of 3 mM ATP.
Following each incubation, the extract was separated into soluble (S)
and insoluble (P) fractions and immunoblotted for NuMA.
(B) Indirect immunofluorescence microscopy was performed on the
samples with and without ATP using a NuMA-specific antibody at
the final time point in the incubation. Bar, 8.7 µm.

in the soluble fraction if the extract is either maintained on
ice or prepared at (or diluted to) 50% the concentration (data
not shown). Finally, examination of the extract by immunofluorescence microscopy following incubation at 30°C for 90
minutes reveals that NuMA is present in numerous, readily
detectable particles that have a somewhat irregular shape
with an average diameter of 1-2 µm (Fig. 1B, −ATP).
Previously, Burke and Gerace (1986) demonstrated that
addition of exogenous sources of ATP inhibited the formation
of nuclei in CHO mitotic cell extracts. To determine if the conversion of NuMA from the soluble fraction to the insoluble
fraction is inhibited by the addition of exogenous ATP we
followed the solubility of NuMA by both immunoblot and
immunofluorescence microscopy in the HeLa cell mitotic
extract supplemented with ATP. Initially, the endogenous ATP
concentration in the mitotic extract prepared under the conditions described here is 300 µM, and it diminishes to <30 µM
within 15 minutes of incubation at 30°C (as determined by
luciferase assay; data not shown). Addition of exogenous ATP
to 3 mM is sufficient to maintain the ATP concentrations in the
extract at >2.5 mM during incubation of the mitotic extract at
30°C for 120 minutes (data not shown). Examination of the
solubility of NuMA by immunoblot reveals that the conversion
of NuMA from the soluble fraction to the insoluble fraction is
severely inhibited when the mitotic extract is supplemented
with ATP (Fig. 1A, +ATP). Consistent with this result, no
NuMA-specific signal was detectable by immunofluorescence
microscopy (Fig. 1B, +ATP). Addition of ATP to the extract
after the conversion of NuMA from the soluble fraction to the
insoluble fraction led to the partial (~50%) reversion of NuMA
from the insoluble fraction to the soluble fraction indicating
that the process is partially reversible by ATP. The inhibitory

1290 A. Saredi, L. Howard and D. A. Compton
nucleolus (fibrillarin, B23, C23, data not shown), nuclear
lamina (Fig. 2), and cytoskeleton (α-tubulin, Fig. 2; vimentin,
actin, Eg5, and γ-tubulin, data not shown). With the exception
of actin (see below), we did not observe an alteration in the
solubility of any of these proteins in the mitotic extract
following incubation at 30°C in either the presence or absence
of exogenously added ATP (Fig. 2). Actin was reproducibly
converted from the soluble fraction to the insoluble fraction
with an efficiency of ~40% in the presence or absence of ATP
(data not shown). Thus, the formation of large, insoluble,
NuMA-containing particles in this mitotic extract is a specific
property of the NuMA protein, and does not represent the nonspecific aggregation of proteins in the extract.

Fig. 2. Conversion of NuMA from
the soluble fraction to the insoluble
fraction in the extract is a specific
process. The mitotic extract was
incubated at 30°C for 120 minutes
either with (+ATP) or without
(−ATP) the addition of 3 mM ATP.
The reactions were then separated
into soluble (S) and insoluble (P)
fractions and immunoblotted for
NuMA, lamins A and C, CENP-F,
and tubulin as indicated.

effect of ATP is most likely due to a requirement for ATP
hydrolysis because addition of 3 mM AMP-PNP does not alter
the conversion of NuMA from the soluble fraction to the
insoluble fraction (data not shown). Taken together, these
results show that large, insoluble, NuMA-containing particles
form spontaneously in a mitotic extract upon incubation at
30°C, and that the formation of these particles is severely
inhibited by the presence of ATP.
To determine if additional proteins undergo an alteration in
solubility similar to NuMA under these conditions, we have
performed immunoblot analysis of the 10,000 g soluble and
insoluble fractions obtained following incubation of the extract
at 30°C for 120 minutes with antibodies recognizing a variety
of cellular proteins (Fig. 2). We have analyzed protein components of the nuclear matrix (CENP-F, Fig. 2; matrin 3, 4, and
F, data not shown), coiled bodies (coilin, data not shown),

A

NuMA’s solubility is regulated by phosphorylation
NuMA is an insoluble component of the nuclear matrix during
interphase, and the formation of insoluble, NuMA-containing
complexes under these conditions suggested that the mitotic
extract may be exiting mitosis during the incubation. To test
this directly we performed two different assays aimed at determining the mitotic state of the extract. First, we determined the
relative activity of p34cdc2/cyclin B using histone H1 as a
substrate (Fig. 3A). Initially, the activity of p34cdc2/cyclin B
is high, consistent with the extract being prepared from synchronized mitotic cells. Following incubation at 30°C for 120
minutes, the p34cdc2/cyclin B activity in the extract supplemented with ATP remained high, but the p34cdc2/cyclin B
activity of the extract lacking ATP was reduced approximately
4- to 5-fold. The second assay that we used to examine the cell
cycle state of the extract was to immunoblot the soluble and
insoluble proteins with the mpm-2 monoclonal antibody which

125

cdc2 kinase activity

100

75

50

25

time 2Hs +ATP
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0

Fig. 3. The extract is becoming non-mitotic during the incubation. (A) Phosphorylation of histone H1 was used to determine the cdc2 kinase
activity in the extract as it is initially prepared (time=0) or after 2 hours incubation at 30°C either with (+ATP) or without (−ATP) the addition
of 3 mM ATP. The results were normalized to the relative value of 100 using the time 0 sample, and are the average of three independent
experiments. (B) The mitotic extract was separated into soluble (S) and insoluble (P) fractions prior to any incubation (0 Hs) or following
incubation at 30°C for 2 hours either with (2 Hs, +ATP) or without (2 Hs, −ATP) the addition of 3 mM ATP. These fractions were then
immunoblotted using the mpm-2 monoclonal antibody which recognizes mitosis-specific phosphoepitopes. The migration position of myosin
(200), β-galactosidase (116), phosphorylase B (97), and bovine serum albumin (66), are indicated on the left and are indicated in kDa.
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recognizes mitosis-specific phosphoepitopes (Fig. 3B; Davis et
al., 1983). Consistent with the results reported by Davis et al.
(1983), a large variety of proteins are recognized by the mpm2 monoclonal antibody in the mitotic extract (Fig. 3B, time=0).
A majority of these antigens remain reactive with the antibody
following incubation of the ATP-supplemented extract for 120
minutes, but nearly all of the antigens become undetectable
upon incubation of the extract in the absence of exogenously
added ATP. Thus, based on the inactivation of p34cdc2/cyclin
B and the loss of the mitosis-specific phosphoepitopes recognized by the mpm-2 monoclonal antibody, we conclude that
the extract has become non-mitotic during the incubation
period.
The exit of the extract from mitosis coupled with the inhibition of the formation of the insoluble, NuMA-containing
particles by ATP hydrolysis suggested that the formation of
these structures may be regulated by phosphorylation. Specifically, the conversion of NuMA from the soluble fraction to the
insoluble fraction in the extract appears to correlate with
protein dephosphorylation. To test if protein dephosphorylation
is required for the formation of the insoluble, NuMA-containing particles we determined the solubility of NuMA in the
mitotic extract in the presence of the protein phosphatase
inhibitors microcystin and okadaic acid (Fig. 4A). Immunoblot

Fig. 4. NuMA’s solubility is regulated by phosphorylation.
(A and B) The mitotic extract was separated into soluble (S) and
insoluble (P) fractions following incubation at 30°C for 2 hours in
the absence of ATP (−ATP) or in the presence of either 3 mM ATP, 1
µM microcystin, 2 µM okadaic acid, or 80 µM staurosporine and 3
mM ATP as indicated. These fractions were then immunoblotted for
NuMA. (C) NuMA was radiolabeled by a brief incubation of the
mitotic extract with [γ-32P]ATP, the reaction performed by incubation
at 30°C for 120 minutes, and NuMA immunoprecipitated from either
the soluble fraction (S) or the insoluble fraction (P). The identical gel
was immunoblotted for NuMA and an autoradiographic exposure to
film was taken to determine the relative 32P content as indicated.

analysis of the soluble and insoluble fractions produced
following incubation at 30°C for 120 minutes demonstrates
that either 1 µM microcystin or 2 µM okadaic acid is sufficient
to completely inhibit the formation of the insoluble, NuMAcontaining particles. The inhibitory effect of these protein
phosphatase inhibitors is similar to the inhibitory effect of ATP
and occurs despite the fact that no exogenous ATP was added
to these extracts. Thus, these results indicate that protein
dephosphorylation is required for the formation of the
insoluble, NuMA-containing particles in the extract under
these conditions.
Based on the fact that protein dephosphorylation is required
for the formation of the insoluble, NuMA-containing structures, we reasoned that protein kinases must be required to
maintain NuMA in the soluble state. To test this idea we determined the solubility of NuMA in the mitotic extract in the
presence of the protein kinase inhibitor staurosporine (Fig. 4B).
Immunoblot analysis of the soluble and insoluble fractions
produced following incubation demonstrates that addition of
80 µM staurosporine to the mitotic extract is sufficient to
promote the formation of the insoluble, NuMA-containing
particles. The promotion of the formation of the insoluble
NuMA-containing structures by the inhibition of protein
kinases using staurosporine occurred despite the presence of
high concentrations of exogenously added ATP demonstrating
that the inhibitory effect of ATP hydrolysis observed earlier is
most likely due to phosphorylation reactions catalyzed by
protein kinases. Thus, these data indicate that protein kinase
activity is essential to maintain NuMA in a soluble state in a
mitotic extract.
To determine if the NuMA protein is being dephosphorylated during the formation of the insoluble complexes we
examined the relative phosphorylation state of NuMA in the
soluble and insoluble fractions. NuMA was radiolabeled by a
brief preincubation at 30°C in the presence of [γ-32P]ATP, the
ATP was then removed by the addition of apyrase, the insoluble
structures formed by incubation at 30°C for 120 minutes, and
the NuMA protein was immunoprecipitated from either the
soluble fraction or the insoluble fraction (Fig. 4C).
Immunoblot analysis of the immunoprecipitates demonstrates
that equal quantities of the NuMA protein have been immunoprecipitated from both soluble and insoluble fractions of the
extract. Autoradiographic exposure of the immunoblot,
however, shows that NuMA derived from the insoluble fraction
contains approximately 3× less phosphate relative to NuMA
derived from the soluble fraction. Thus, the NuMA protein is
dephosphorylated during the formation of the insoluble
NuMA-containing particles.
Ultrastructure of the NuMA-containing particles
To thoroughly characterize the insoluble structures formed by
NuMA under these conditions, we examined their ultrastructure by transmission electron microscopy (TEM). For this
analysis we fixed, embedded and sectioned the insoluble pellet
fraction produced following incubation of the mitotic extract
at 30°C for 120 minutes. Examination of this pellet at high resolution by TEM reveals four predominant structures (Fig. 5).
First, there are membrane vesicles that are present to varying
degrees depending on the particular extract and are probably
contaminants from the 100,000 g centrifugation step used for
the preparation of the mitotic extract. Second, there are
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Fig. 5. Transmission electron
microscopic analysis of the insoluble
pellet formed following the incubation
of the mitotic extract at 30°C for 120
minutes. Arrows point to the dense
spherical particles and arrowheads point
to the particles composed of an
interconnected network of foci. Bars:
430 nm (A), 86 nm (B).

extensive bundles of filaments whose morphology is consistent
with actin fibers. The observation of actin fibers by TEM
agrees with our observation that, like NuMA, a significant proportion of actin is converted from a soluble form to an insoluble
form during the incubation period. Finally, there are two
different classes of particles that have diameters ranging from
0.5-2 µm. One class of particle has a relatively uniform
spherical shape and diameter (~0.5 µm) with a biphasic texture
composed of a dense central core surrounded by a granular
layer (Fig. 5A and B, arrows). These particles resemble prenucleolar bodies described in other systems (Bell and Scheer,
1996; Trimbur and Walsh, 1993) and will be referred to
throughout this article as dense spherical particles. The second
class of particle is less uniform in size and shape, has a more

open organization, and is composed of a complicated threedimensional network of interconnected foci (Fig. 5A and B,
arrowheads). The individual foci are approximately 70 nm in
diameter and separated from the neighboring foci, on average,
by 90 nm. Except for the contaminating vesicles all of these
structures were resistant to extraction with Triton X-100 (data
not shown).
To determine which of the particles in the insoluble fraction
contain NuMA we performed immunogold electron
microscopy using a rabbit antibody that is specific for the
human NuMA protein. Fig. 6 shows that the gold particles are
distributed relatively uniformly, and almost exclusively
throughout the particles composed of the interconnected
network of foci. Less than 1% of the gold particles were found
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Fig. 6. NuMA is contained exclusively in
the particles composed of interconnected
foci. The insoluble pellet was formed by
incubation of the mitotic extract at 30°C for
120 minutes, and NuMA was localized by
immunogold electron microscopy using the
NuMA-specific rabbit serum followed by 5
nm gold-conjugated goat anti-rabbit serum.
Bar, 86 nm.

distributed in other areas of the section, and no significant decoration of either the vesicles, actin fibers, or dense spherical
particles was observed. The gold particle decoration of the
particles composed of interconnected foci by the NuMAreactive antibody was specific because no significant decoration of any structure was observed if we eliminated the primary
antibody from the reaction (data not shown). Thus, the NuMA
protein is restricted to the particles that are composed of the
interconnected array of foci.
To determine if the formation of these complex particles
requires the NuMA protein, we have used the NuMA-specific
antibody to deplete NuMA from the extract prior to incubation
at 30°C (Fig. 7). As a control, we treated the extract in an
identical manner using a preimmune antibody. Immunoblot
analysis of the immune pellets and the subsequent supernatants
following depletion with either the NuMA-specific antibody or
the preimmune antibody indicates that >98% of the NuMA
protein is depleted from the extract using the NuMA-specific
antibody while the preimmune antibody has no effect on the
distribution of NuMA (Fig. 7A). Three sequential immunodepletion steps are required to efficiently deplete NuMA from
the extract, and each of these sequential immune pellets is
analyzed separately in Fig. 7A. Following the depletion of the
extract with the preimmune serum a significant fraction of
NuMA was converted to an insoluble form upon incubation in
the absence of ATP indicating that the three sequential
depletion steps had not altered the activity of the mitotic extract
(Fig. 7A, preimmune, lane −ATP). Furthermore, NuMA is the
only protein depleted from these extracts because both we and
others have demonstrated that NuMA is not in a pre-assembled
protein complex in nocodazole-treated mitotic cell extracts
(Gaglio et al., 1995; Kempf et al., 1994; Kallajoki et al., 1993).
Following the immunodepletion steps we collected the

supernatant, incubated the samples at 30°C for 120 minutes,
and performed TEM on the insoluble fraction (Fig. 7B).
Immunodepletion with the preimmune antibody resulted in no
detectable difference in the morphology of the actin filaments,
the dense spherical particles, or the NuMA-containing
particles. Following the depletion of NuMA, however, the
particles composed of interconnected foci that contain NuMA
were virtually absent (Fig. 7B). In contrast, the actin filaments
and the dense spherical particles appeared to form normally
and were morphologically indistinguishable from their counterparts formed in the extract that has been depleted using the
preimmune antibody. To quantitate the effects of the depletion
of NuMA from the extract, we compared the number of dense
spherical particles to the number of NuMA-containing
particles in the extracts depleted with either the preimmune
antibody or the NuMA-specific antibody (Fig. 7C). Following
the depletion of the mitotic extract with the preimmune
antibody the NuMA-containing particles slightly outnumber
the dense spherical particles (ratio = 1.6). In the absence of
NuMA, however, there are approximately 70× fewer NuMAcontaining particles relative to the dense spherical particles
(ratio = 0.014). Thus, these data demonstrate that NuMA is an
essential structural component of the particles composed of the
complex, interconnected foci.
DISCUSSION
The NuMA protein progresses through a complex series of solubility changes as it changes localization during mitosis (Fig.
8, in vivo). During interphase, NuMA is an insoluble
component of the nuclear matrix. When the nucleus disassembles at the onset of mitosis, NuMA is rendered soluble and

1294 A. Saredi, L. Howard and D. A. Compton

C
Number of particles

80

60

40

20

PREIMMUNE

Dense
Particles

NuMA
Particles

Dense
Particles

NuMA
Particles

0

ANTI-NuMA

Fig. 7. NuMA is an essential structural component of the particles composed of interconnected foci. (A) The mitotic extract was depleted using
either a preimmune antibody or the NuMA-specific antibody as indicated. Immunoblot analysis of the immune pellets derived from the three
sequential immunodepletion (IP1, 2, and 3), and the soluble (S) and insoluble (P) fractions produced following incubation at 30°C for 120
minutes in the absence of ATP (−ATP) or presence (+ATP) of 3 mM ATP shows the distribution of NuMA and verifies that the depletion has
been ~98% efficient. (B) Transmission electron microscopy of the insoluble pellet produced following the depletion of the mitotic extract with
either the preimmune antibody or the NuMA-specific antibody as indicated. Bar, 86 nm. (C) The effects of NuMA depletion were quantitated
from two separate experiments by counting the relative number of the NuMA-containing particles and the dense spherical particles following
the depletion of the mitotic extract with either the preimmune antibody or the NuMA-specific antibody.

targets to the microtubules of the mitotic spindle where it
becomes insoluble by virtue of its attachment to the micro-

tubules. If microtubule polymerization is prevented, however,
NuMA remains soluble in mitosis following nuclear envelope
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Fig. 8. The solubility of NuMA is regulated by phosphorylation. In
vivo, NuMA progresses through at least two discrete phosphorylation
events during mitosis as it moves from the nuclear matrix through a
transient soluble intermediate to the mitotic spindle pole. The in vitro
reaction described here demonstrates that the maintenance of NuMA
in the soluble state requires active protein phosphorylation by protein
kinases. On the other hand, if protein phosphatase activity
predominates then NuMA and additional cellular proteins are
converted through a specific process into large insoluble complexes.
The formation of these complexes probably represents the conversion
of NuMA from the soluble mitotic form to the insoluble interphase
form.

mitosis (Price and Pettijohn, 1986; Compton and Luo, 1995;
Gaglio et al., 1995; Hsu and Yeh, 1996; Sparks et al., 1995).
The sum of these data indicate that NuMA undergoes one phosphorylation event at the onset of mitosis concomitant with
nuclear envelope breakdown and a second phosphorylation
event upon association with the mitotic spindle (Gaglio et al.,
1995; Hsu and Yeh, 1996). Following the completion of
mitosis, protein phosphatases revert NuMA to its least phosphorylated state, but only after it has been imported into the
nucleus in the subsequent G1 phase of the cell cycle (Sparks et
al., 1995). The correlation between NuMA’s phosphorylation
status and the timing of nuclear disassembly and reassembly
combined with the present data demonstrating that dephosphorylation catalyzes the conversion of NuMA from a soluble
protein to an insoluble protein indicates that there may be both
spatial and temporal regulation to the cell cycle-dependent
phosphorylation of NuMA. Indeed, our results would suggest
that by spatially limiting the dephosphorylation of NuMA to
the nuclear interior following the completion of mitosis, the
possibility of accumulating the insoluble form of NuMA in the
cell cytoplasm at the end of mitosis would be eliminated.
At present, the identity of the protein kinases and/or phosphatases responsible for the regulation of NuMAs dynamic
behavior are unknown. NuMA is phosphorylated by
p34cdc2/cyclin B (Hsu and Yeh, 1996), and mutant forms of
NuMA lacking the p34cdc2/cyclin B phosphorylation sites do
not target to the mitotic spindle suggesting that this phosphorylation event plays a key role in the targeting of NuMA
(Compton and Luo, 1995). These mutant forms of NuMA,
however, remain insoluble when dispersed throughout the
cytoplasm of the mitotic cells as judged by extraction with
Triton X-100. Thus, while p34cdc2/cyclin B-dependent phosphorylation appears important for some aspects of NuMA’s
mitotic regulation, there are probably additional protein
kinases acting on NuMA that promote its release from the
nuclear compartment when the nucleus breaks down at the
onset of mitosis. The combination of the experimental system
described here and the experimental system developed for
NuMA’s role in organizing the mitotic spindle (Gaglio et al.,
1995) should permit a detailed investigation into the identity
and role of protein kinases and phosphatases that modulate
NuMA’s activity.

break down and it is under these conditions that we prepare the
mitotic extract. Surprisingly, we find that upon incubation in
the absence of exogenously added ATP the extract becomes
non-mitotic and NuMA spontaneously assembles into specific,
insoluble particles. These results, in combination with the
previous findings of Burke and Gerace (1989) demonstrating
that several aspects of interphase nuclei form in somatic cell
mitotic extracts under similar experimental conditions, lead us
to conclude that this cell free system is mimicking the reaction
by which NuMA changes from a soluble protein in mitosis to
an insoluble protein in interphase (Fig. 8, in vitro).
By manipulating the mitotic extract in this manner, we have
generated evidence showing that the cell cycle-dependent
changes in NuMA’s solubility are regulated by phosphorylation (Fig. 8, in vitro). Both we and others have shown that
NuMA is a phosphoprotein that undergoes (at least) two
discrete phosphorylation events during the progression of

NuMA is a structural protein
The primary amino acid sequence of NuMA contains an
extensive region predicted to fold into a α-helical coiled-coil
(Compton et al., 1992; Yang et al., 1992; Maekawa and
Kuriyama, 1993; Tang et al., 1993) suggesting that NuMA
performs a structural function in the cell. Consistent with this
view we show here that NuMA is an essential structural
component of large, insoluble particles that form spontaneously when the extract becomes non-mitotic. These
particles are composed of a dense array of interconnected foci
that form through a specific process because we could not
identify any other proteins with similar solubility properties
under these experimental conditions (actin undergoes a solubility change under these conditions, but it polymerizes independently of NuMA or ATP; see Fig. 5A). The organization of
these particles from interconnected foci bears a remarkable
resemblance to the structures that form when NuMA is
expressed in the cell cytoplasm (Saredi et al., 1996), and
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suggests that this type of organization may be the fundamental assembly pattern of the NuMA protein. The complex structures we observe using these two independent methods,
however, differ markedly from the simple parallel, coiled-coil
dimers that are formed by the recombinant NuMA protein
expressed in bacteria and purified following denaturation with
urea (Harborth et al., 1995). The most likely explanation for
this discrepancy is that the parallel dimers formed by the
purified recombinant protein are the first step in the assembly
process for NuMA, and the more complex structures that we
have observed under more physiological conditions (this report
and that of Saredi et al., 1996) are derived from those simple
dimeric molecules.
It is important to note, however, that the structures formed
in the mitotic extract under the conditions described here and
following the expression of NuMA in the cell cytoplasm are
not identical. They share a common organization in that they
are large, insoluble particles composed of interconnected foci,
but they differ in fine detail. For example, the individual foci
have larger diameters when NuMA is assembled by dephosphorylation in the mitotic extract compared to the foci formed
by NuMA in the interphase cytoplasm in the presence of either
taxol or nocodazole. Furthermore, the resolution of a filamentous network separating each of the foci which is clearly
evident following the expression of NuMA in the cell
cytoplasm is not well resolved in the structures described here.
We attribute these structural differences to the presence of
additional cellular proteins present within the NuMA-containing particles formed following dephosphorylation in the
mitotic extract that are not present in the particles formed by
NuMA when it is expressed in the cell cytoplasm. Support for
this interpretation comes from the fact that the particles formed
by NuMA when it is expressed in the cell cytoplasm are biochemically pure, and are composed exclusively of NuMA
(Saredi et al., 1996). Unfortunately, we have not been able to
determine if additional cellular proteins are associated with the
NuMA particles produced in the mitotic extract because the
polymerization of extensive actin-containing arrays renders the
extract too viscous to successfully purify the NuMA-containing particles from the mitotic extract.
In summary, the results presented here support the conclusion that NuMA serves a structural role in the cell. Prevailing evidence indicates that one structural role that NuMA
fulfills is for the organization of microtubule minus ends at
the polar ends of the mitotic spindle (Gaglio et al., 1995,
1996; Merdes et al., 1996; Yang and Snyder, 1992; Kallajoki
et al., 1991). The question as to whether NuMA provides an
independent structural function within the nucleus during
interphase is still unresolved. NuMA is expressed and
localized in nuclei of terminally differentiated (non-dividing)
cells (Kallajoki et al., 1992; Tang et al., 1993) suggesting a
specific nuclear role, however, studies using both cultured
cells and Xenopus egg extracts have found that nuclei
assemble with grossly normal three-dimensional morphology
in the absence of NuMA (Yang and Snyder, 1992; A. Merdes
and D. W. Cleveland, personal communication). These data
suggest that if NuMA serves a structural function within the
cell nucleus during interphase it is either non-essential for the
three-dimensional architecture of the nucleus or covered by
an as yet unidentified redundant structural mechanism. Alternatively, NuMA may be sequestered in the cell nucleus during

interphase as part of its spatial and temporal regulation. Our
current findings showing that NuMA forms insoluble structures upon dephosphorylation combined with our previous
results showing that NuMA may perturb microtubule
structure in the cytoplasm during interphase (Saredi et al.,
1996) provides ample justification for sequestering NuMA in
the nucleus during interphase.
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